Source: Annual Congress 2013 –Clinical studies in lung transplantation



Rating:

Share or cite this content

Citations should be made in the following way:
F. Ihle, M. Griese, W. von Wulffen, R. Hatz, J. Behr, C. Neurohr (Munich, Germany). Aerosolized liposomal cyclosporine A for treatment of progressive allograft dysfunction following lung transplantation. Eur Respir J 2013; 42: Suppl. 57, 2679

Member's Comments

No comment yet.

Related content which might interest you: Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans Source: Eur Respir J 2004; 23: 384-390 Year: 2004 Long-term kinetics of CD19+CD24highCD38highBreg cells in lung transplant recipients Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms Year: 2016 Negative consequences of immunosuppressive therapy on bronchial healing following lung transplantation (LTx) Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 A model of chronic lung allograft rejection in the rat Source: Eur Respir J 2010; 35: 1354-1363 Year: 2010 Total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment Year: 2014 Immunosuppressive therapy after human lung transplantation Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=105 Year: 2003 Early sirolimus immunosuppression is safe in lung transplantation Source: Annual Congress 2012 - Optimising outcomes after lung transplantation Year: 2012 Hypogammaglobulinemia in lung transplant candidates Source: International Congress 2016 – Long-term outcomes of lung transplantation Year: 2016 Hepatic veno-occlusive disease due to tacrolimus in a single-lung transplant patient Source: Eur Respir J 2006; 27: 1066-1068 Year: 2006 Azathioprine discontinuation and medium and long term outcomes after lung transplantation Source: International Congress 2015 – Outcomes of lung transplantation Year: 2015 Pulmonary alveolar proteinosis due to mycophenolate and cyclosporine combination therapy in a renal transplant recipient Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach Year: 2012 LATE-BREAKING ABSTRACT: Challenging immunosuppression treatment in lung transplant patients with kidney failure: Rescue therapy with basiliximab? Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD Year: 2015 A new biomarker for chronic lung allograft dysfunction Source: International Congress 2014 – Chronic lung allograft dysfunction: mechanisms, predictors and phenotypes Year: 2014 Pirfenidone stabilizes pulmonary function and reduces 18F-FDG-uptake in restrictive allograft syndrome following lung transplantation Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment Year: 2014 A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation Source: Eur Respir J 2011; 37: 164-172 Year: 2011 Azithromycin (Azi) treatment for chronic allograft dysfunction after lung transplantation (LTx) Source: Annual Congress 2003 - Bronchiolitis obliterans: diagnosis and treatment Year: 2003 Effect of extracorporeal photopheresis on respiratory function in hematopoietic stem cell transplant recipients Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients Year: 2014 Pirfenidone treatment in patients with bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation Source: International Congress 2016 – Orphan diseases II Year: 2016 Post-transplant bronchiolitis obliterans Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=158 Year: 2003 Lung biopsy predicts outcome in bronchiolitis obliterans following allogeneic stemcell transplantation Source: Annual Congress 2011 - General thoracic surgery I Year: 2011